Neurodegenerative Diseases
Neurodegenerative diseases are pathological conditions characterized by the functional loss, structural degeneration, and progressive cell death of neurons within the central nervous system. Conditions such as Alzheimer’s, Parkinson’s, and Huntington’s disease fall into this category. Genetic testing allows for the comprehensive assessment of an individual’s genetic risk profile for these conditions.
Alzheimer’s Disease
Dementia (loss of cognitive functions) is the most prevalent form of neurodegenerative disease, with Alzheimer’s disease accounting for 70% of all cases. Alzheimer’s is caused by the abnormal accumulation of amyloid-beta plaques and tau proteins in the brain, resulting in the loss of essential cognitive abilities such as thinking, learning, and memory.
Risk Groups:
Individuals aged 65 and older.
Those with a family history of Alzheimer’s disease (particularly among first-degree relatives).
Comprehensive Genetic Analysis:
With our specialized Neurodegenerative Panel, we analyze 57 different genes associated with Alzheimer’s and dementia, including critical markers such as APOE, to establish detailed genetic risk profiles.
Technical Specifications
Feature | Details |
Method | NGS (Next-Generation Sequencing) |
Coverage | 57+ Genes |
Sample Requirement | Blood (EDTA Tube) |
Turnaround Time (TAT) | 4-6 Weeks |
*For a detailed sample collection, please contact our team.
19 Mayıs Mah. Çoruh Sok. No:32/1 Fulya, 34394 Şişli / Istanbul, Turkey
Monday - Friday 09:00 - 18:00 Saturday 09:00 - 14:00